How Recursion Pharmaceuticals makes money

Period

FY2025

How does Recursion Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Recursion Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31

Revenue$75MNet loss$645M · 863%Cost of revenue$71M · 95%Gross profit$4M · 5%Operating expenses$652M · 873%Other income$3M · 5%R&D$475M · 636%SG&A$177M · 236%License & Service$74M · 99%Grant$425000 · 1%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.